|
Enzymes- Private Companies ReportPublished by: Freedonia Group Inc Published: Jan. 1, 2001 - 192 Pages Table of ContentsIntroduction
AbstractPrivate and start-up firms play an active role in the $1.8 billion US specialty and industrial enzyme industry. In 1999, the top two private companies had total enzyme sales of over $25 million. In addition, 16 other private and start-up firms had total sales over $25 million, including products other than enzymes. This report profiles more than 100 privately-held US companies (e.g., Altus Biologies, Promega). It also provides market share data, list companies by product and location, and forecasts industry demand.Please Note: Freedonia requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||